Having a larger brain tumor at diagnosis is associated with a higher risk of death, longer hospital stays, and greater neurological deficits, a study suggests.

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025.

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

Foley did not direct "Fifty Shades of Grey", but did join the franchise to direct both its sequels, "Fifty Shades Darker" and "Fifty Shades Freed", after the departure of Sam Taylor-Johnson following ...

Move to Promote GBM, Ride for Don, Julia Coey Memorial, and Farands for the Fight.” Brain Cancer Canada is a national charity dedicated to improving the lives of those affected by primary malignant ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system more effectively than traditional therapies, particularly against evasive and ...

Check out the latest oncology news from this week, including highlights from the 2025 American Association for Cancer Research and American Urological Association annual meetings.

The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

The anti-GD2 therapy naxitamab has been included in the NCCN Clinical Practice Guidelines in Oncology for the treatment of ...

The project, titled “Exploring microRNA as Targets for Glioblastoma Therapy”, focuses on developing novel therapeutic strategies to address one of the most aggressive and treatment-resistant ...

ImmunityBio's sBLA for Anktiva was unexpectedly rejected by the FDA, contradicting prior positive feedback and approval for a ...